基本信息
浏览量:10
职业迁徙
个人简介
Biography
Dr. Preston C. Sprenkle specializes in the treatment of urologic cancers, including prostate cancer, kidney cancer, bladder cancer, testicular cancer and sarcoma – a rare kind of cancer that grows in cells that connect or support other parts of the body, like bone or muscle.
Dr. Sprenkle has dedicated his career to using the latest imaging technologies to improve diagnosis. He was one of the first physicians nationwide to implement the use of the Artemis Device. This machine, introduced in 2009, allows a surgeon to use 3D ultrasound technology and merge it with even more precise magnetic resonance imaging (MRI) to accurately identify cancerous tumors.
“Skilled and experienced radiologists are rare for this relatively new technique,” Dr. Sprenkle explains. “At Yale, we are fortunate to have some of the world leaders in prostate MRI.”
Dr. Sprenkle is also a pioneer in “focal therapy,” which allows a surgeon to treat tiny prostate lesions, rather than the whole organ. This avoids many of the side effects—such as erectile dysfunction and incontinence—that may follow the removal of the whole prostate.
“Exciting technological advances are revolutionizing urology. Prostate cancer is very common and current treatments can majorly impact a man's sexual and urinary function,” Dr. Sprenkle says. “Developing ways to minimize the impact of prostate cancer diagnosis and treatment on a man's health and quality of life is tremendously rewarding.”
Dr. Sprenkle believes in working with patients to come up with individualized treatment plans. “I want my patients to feel that I hear their concerns and treat them like a person. I am pleased at the end of a long consultation when they feel like they understand their disease and their options.”
Dr. Preston C. Sprenkle specializes in the treatment of urologic cancers, including prostate cancer, kidney cancer, bladder cancer, testicular cancer and sarcoma – a rare kind of cancer that grows in cells that connect or support other parts of the body, like bone or muscle.
Dr. Sprenkle has dedicated his career to using the latest imaging technologies to improve diagnosis. He was one of the first physicians nationwide to implement the use of the Artemis Device. This machine, introduced in 2009, allows a surgeon to use 3D ultrasound technology and merge it with even more precise magnetic resonance imaging (MRI) to accurately identify cancerous tumors.
“Skilled and experienced radiologists are rare for this relatively new technique,” Dr. Sprenkle explains. “At Yale, we are fortunate to have some of the world leaders in prostate MRI.”
Dr. Sprenkle is also a pioneer in “focal therapy,” which allows a surgeon to treat tiny prostate lesions, rather than the whole organ. This avoids many of the side effects—such as erectile dysfunction and incontinence—that may follow the removal of the whole prostate.
“Exciting technological advances are revolutionizing urology. Prostate cancer is very common and current treatments can majorly impact a man's sexual and urinary function,” Dr. Sprenkle says. “Developing ways to minimize the impact of prostate cancer diagnosis and treatment on a man's health and quality of life is tremendously rewarding.”
Dr. Sprenkle believes in working with patients to come up with individualized treatment plans. “I want my patients to feel that I hear their concerns and treat them like a person. I am pleased at the end of a long consultation when they feel like they understand their disease and their options.”
研究兴趣
论文共 140 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Luke A. R. Shumaker, Andrew Fang,Masatomo Kaneko, Lorenzo Ramacciotti, Nachiketh Prakash, Arighno Das,Hiten Patel,Ghazal Khajir,Richard Fan,Shu Wang, Kevin Pineault, Abhinav Sidana,Gopal Gupta, Christopher Filson, James Wysock, M. Minhaj Siddiqui,Geoffrey A. Sonn,Preston Sprenkle,Ashley Ross, David Jarrard,Sanoj Punnen,Andre Abreu,Soroush Rais-Bahrami
JOURNAL OF UROLOGYno. 5 (2024): E316-E317
引用0浏览0引用
0
0
Vinaik M. Sundaresan, Shayan Smani,Pawel Rajwa,Joseph Renzulli,Preston C. Sprenkle, Isaac Y. Kim,Michael S. Leapman
Urologic Oncology Seminars and Original Investigations (2024)
JOURNAL OF UROLOGYno. 5 (2024): E972-E972
Michael S. Leapman, Julian Ho, Yang Liu, Christopher Filson, Xin Zhao,Alexander Hakansson,James A. Proudfoot,Elai Davicioni,Darryl T. Martin,Yi An,Tyler M. Seibert,Daniel W. Lin,Daniel E. Spratt,Matthew R. Cooperberg,Preston C. Sprenkle,Ashley E. Ross
European Urology Oncology (2024)
Gabriela M Diaz,Lindsey T Webb, Maximilian J Rabil,Soum D Lokeshwar,Ankur U Choksi,Michael S Leapman,Preston C Sprenkle
Current urology reportsno. 10 (2024): 243-252
Michael S. Leapman, Julian Ho, Yang Liu, Christopher P. Filson, Xin Zhao,Alexander Hakansson,James A. Proudfoot,Elai Davicioni,Darryl T. Martin,Yi An,Tyler M. Seibert,Daniel W. Lin,Daniel E. Spratt,Matthew R. Cooperberg,Ashley E. Ross,Preston C. Sprenkle
JAMA NETWORK OPENno. 6 (2024)
Luke A. R. Shumaker,Andrew Fang,Masatomo Kaneko, Lorenzo Ramacciotti, Nachiketh Prakash,Arighno Das,Hiten Patel,Ghazal Khajir,Richard Fan,Shu Wang, Kevin Pineault,Abhinav Sidana,Gopal Gupta,Christopher Filson,James Wysock,M. Minhaj Siddiqui,Geoffrey A. Sonn,Preston Sprenkle,Ashley Ross,David Jarrard,Sanoj Punnen,Andre Abreu,Soroush Rais-Bahrami
Maximilian J. Rabil,Michael Jalfon,Dylan Heckscher, Zhiqian Song, Fangyong Li, Thomas Martin,Preston C. Sprenkle, David Hesse,Isaac Y. Kim,Michael S. Leapman,Jaime A. Cavallo
Urology (2024)
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONSno. 2 (2024): 28.e9-28.e20
加载更多
作者统计
#Papers: 141
#Citation: 1245
H-Index: 18
G-Index: 34
Sociability: 6
Diversity: 2
Activity: 48
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn